Kringle Pharma, Inc. Aktie - Unternehmensdaten & Kurse - JP3270790003 | goSPATZ

Kringle Pharma, Inc.

Share · JP3270790003 (XTKS)

No Price

Closing Price XTKS 09.12.2025: 390,00 JPY

09.12.2025 05:41

Current Prices from Kringle Pharma, Inc.

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
Tokyo	4884.T	JPY	09.12.2025 05:41	390,00 JPY	-3,00 JPY -0,76 %

Share Float & Liquidity

Free Float 84,24 %

Shares Float 5,76 M

Shares Outstanding 6,84 M

Company Profile for Kringle Pharma, Inc. Share

Kringle Pharma, Inc. engages in the research and development, manufactures, and sells hepatocyte growth factor (HGF) protein pharmaceuticals for regenerative medicines. The company develops HGF products for the treatment of acute spinal cord injury, amyotrophic lateral sclerosis, vocal fold scar, and acute kidney injury. Kringle Pharma, Inc. was incorporated in 2001 and is based in Ibaraki, Japan.

Get up to date insights from finAgent about Kringle Pharma, Inc.

Company Data

Name Kringle Pharma, Inc.

Company Kringle Pharma, Inc.

Website https://www.kringle-pharma.com

Primary Exchange

Tokyo

ISIN JP3270790003

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Kiichi Adachi

Market Capitalization 3 Mrd.

Country Japan

Currency JPY

Employees 0,0 T

Address 207 Saito Bio Incubator, 567-0085 Ibaraki

IPO Date 2020-12-28

Ticker Symbols

Name	Symbol
Tokyo	4884.T

More Shares

Investors who hold Kringle Pharma, Inc. also have the following shares in their portfolio:

ENW FINANCE 23/32 Bond

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog

Im App Store herunterladen

Bei Google Play herunterladen

All rights reserved © LCP GmbH 2025